GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Stryker Corporation (SYK) [hlAlert]

Rating:
Perform SYK
up 119.73 %

Stryker Corporation (SYK) rated Perform with price target $56 by Oppenheimer

Posted on: Thursday,  Oct 18, 2012  8:25 AM ET by Oppenheimer

Oppenheimer rated Perform Stryker Corporation (NYSE: SYK) on 10/18/2012. Previously Oppenheimer rated Outperform Stryker Corporation (NYSE: SYK) on 09/08/2010., when
the stock price was $46.00. Since then, Stryker Corporation has gained 119.74% as of 01/08/2016's recent price of $101.08.
If you would have followed the previous Oppenheimer's recommendation on SYK, you would have gained 119.73% of your investment in 1948 days.

Stryker Corporation (Stryker) is a medical technology company with a range of products in orthopaedics and a presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose and throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. The Company operates in two business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, craniomaxillofacial and spinal implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/18/2012 8:25 AM Buy
None
52.04 56.00
as of 12/31/2012
1 Week down  -1.87 %
1 Month up  1.21 %
3 Months down  -1.50 %
1 YTD up  10.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/6/2011 8:25 AM Buy
None
61.00 68.00
1/11/2011 8:25 AM Buy
None
58.27 61.00
9/8/2010 8:25 AM Buy
None
46.00 57.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy